A study of more than 1,000 Hispanic adults with hypertension found increased health literacy improves patients’ adherence to blood pressure medications—but the majority of the population struggles with poor health literacy, indicating a need for tailored interventions.

Following a series of valsartan recalls over carcinogenic impurities, at least three sellers of the popular blood-pressure medication hiked their prices, the Wall Street Journal reported.

A Harvard-led study of 130 hypertensive individuals found a unique home-based blood pressure (BP) control program run by non-physicians can help patients reach healthy BP goals within seven weeks.

In the past year bone broth—the result of simmering animal bones with herbs and vegetables for anywhere between 20 minutes and 20 hours—has been lauded as a superfood, promoted as a Hollywood diet and linked to benefits like better gut health and stronger joints. Now, research out of Spain is proving at least some of those claims are true.

The 2017 U.S. hypertension guidelines rightly recommend lifestyle modifications for a large proportion of patients with high blood pressure, noted the authors of a new editorial, but those guidelines fall short in addressing exactly how to facilitate those changes.

Hypertensive patients who had periventricular white matter abnormalities progress from one brain scan to the next showed a six-fold increased risk of mild cognitive impairment, researchers reported Jan. 4 in Hypertension.

Omron Healthcare opened its latest product, a wearable blood pressure cuff that dually acts as a smartwatch, to presales Dec. 20 ahead of the device’s official launch in January 2019.

The impressive blood pressure reductions seen among hypertensive black men participating in a barbershop-based intervention were sustained through one year, according to a follow-up study published Dec. 17 in Circulation.

Amazon has teamed up with product developer Omron Healthcare to integrate its Alexa voice assistant with Omron’s family of blood pressure monitors, CNBC reported. The move is expected to help heart patients better manage their BP.

Ambulatory blood pressure monitoring (ABPM) is cost-saving across nearly all age groups, regardless of whether patients are found to have hypertension on the initial screening, according to a study published in Hypertension.

Mylan Pharmaceuticals expanded its voluntary drug recall to include all unexpired valsartan-containing products in the U.S., the FDA announced Dec. 4. The action joins a host of other recalls over the last few months related to carcinogenic impurities being found in angiotensin II receptor blockers (ARBs), a class of medications used to treat hypertension and heart failure.

Contrary to U.S. guidelines, early action against high BP in patients exhibiting signs of hypertension doesn’t reduce their risk of heart disease later in life, according to a study published in the European Heart Journal Nov. 21.